Molecular mechanism of miRNA regulating PD-L1 expression

被引:0
|
作者
Zhao, Wenxin [1 ,2 ]
Li, Xiaolan [1 ,2 ]
Ren, Qunli [1 ,2 ]
Wang, Qian [1 ,2 ]
Liao, Chengcheng [2 ]
Ding, Tianhao [2 ]
Li, Ping [1 ]
Liu, Jianguo [2 ]
机构
[1] Zunyi Med Univ, Microbial Resources & Drug Dev Key Lab Guizhou Ter, Sch Stomatol, Zunyi 563000, Peoples R China
[2] Zunyi Med Univ, Sch Clin Med, Zunyi 563000, Peoples R China
来源
GENE REPORTS | 2023年 / 31卷
关键词
PD-L1; miRNA; Immune checkpoint; Molecular regulation; Tumor suppressor gene; BREAST-CANCER; TARGETS PD-L1;
D O I
10.1016/j.genrep.2023.101763
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
PD-L1 (programmed death-ligand 1) binding to PD-1 (programmed cell death protein 1) reduces the proliferation of PD-1-positive cells, inhibits their cytokine secretion, and induces apoptosis. miRNA (microRNA) as an important regulator of gene expression, affects the performance of gene function. Similarly, the expression of PDL1 is also regulated by miRNA. miRNAs usually negatively regulate gene expression, however, is there positive regulation? We reviewed the molecular mechanisms of the positive and negative regulation of PD-L1 expression by miRNAs. miRNAs mainly indirectly and positively regulate PD-L1 expression through the regulation of tumor suppressor genes PTEN (phosphatase and tensin homolog) and LATS2 (large tumor suppressor kinase 2), oncogene YAP1 (Yes1 associated transcriptional regulator), DNA damage response protein Ku80 (80-kilodalton subunit of the Ku heterodimer protein), etc., while negative regulation is mainly achieved by miRNAs directly binding to the 3 & PRIME;-UTR (3 & PRIME; untranslated region) of PD-L1 mRNA. And this negative regulation can also be reversed by the negative regulation of miRNAs by RNA-binding protein LIN28 (protein lin-28) or circRNAs (circular RNA) such as cire0000284 and circ-CPA4. The revealing of this mechanism provides more references and strategies for immune checkpoint therapy of tumors.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Recent advances of molecular mechanisms of regulating PD-L1 expression in melanoma
    Han, Jiaqian
    Xu, Xiaobo
    Liu, Zi
    Li, Zengqiang
    Wu, Yingliang
    Zuo, Daiying
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 88
  • [2] The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint
    Wang, Qingshui
    Lin, Wei
    Tang, Xiaoqiong
    Li, Suhuan
    Guo, Libin
    Lin, Yao
    Kwok, Hang Fai
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
  • [3] Mechanisms regulating PD-L1 expression on tumor and immune cells
    Chen, Shuming
    Crabill, George A.
    Pritchard, Theresa S.
    McMiller, Tracee L.
    Wei, Ping
    Pardoll, Drew M.
    Pan, Fan
    Topalian, Suzanne L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [4] Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
    Garcia-Diaz, Angel
    Shin, Daniel Sanghoon
    Moreno, Blanca Homet
    Saco, Justin
    Escuin-Ordinas, Helena
    Rodriguez, Gabriel Abril
    Zaretsky, Jesse M.
    Sun, Lu
    Hugo, Willy
    Wang, Xiaoyan
    Parisi, Giulia
    Saus, Cristina Puig
    Torrejon, Davis Y.
    Graeber, Thomas G.
    Comin-Anduix, Begonya
    Hu-Lieskovan, Siwen
    Damoiseaux, Robert
    Lo, Roger S.
    Ribas, Antoni
    CELL REPORTS, 2017, 19 (06): : 1189 - 1201
  • [5] Radiopharmacology and molecular imaging of PD-L1 expression in cancer
    Vaz, Sofia Carrilho
    Capacho, Ana Sofia
    Oliveira, Francisco P.
    Gil, Nuno
    Barros, Carla Teixeira
    Parreira, Antonio
    Costa, Durval C.
    CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (06) : 429 - 439
  • [6] Radiopharmacology and molecular imaging of PD-L1 expression in cancer
    Sofia Carrilho Vaz
    Ana Sofia Capacho
    Francisco P. Oliveira
    Nuno Gil
    Carla Teixeira Barros
    António Parreira
    Durval C. Costa
    Clinical and Translational Imaging, 2018, 6 : 429 - 439
  • [7] PD-1/PD-L1 expression and molecular associations in HPB malignancies
    Mody, Kabir
    Feldman, Rebecca
    Reddy, Sandeep K.
    Reynolds, Gina A.
    McMillan, Jessica M.
    Johnson, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [8] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [9] Molecular Mechanism of Small-Molecule Inhibitors in Blocking the PD-1/PD-L1 Pathway through PD-L1 Dimerization
    Guo, Yan
    Jin, Yulong
    Wang, Bingfeng
    Liu, Boping
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [10] Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma
    Koh, Young wha
    Han, Jae-ho
    Haam, Seokjin
    Lee, Hyun woo
    ANTICANCER RESEARCH, 2024, 44 (05) : 2081 - 2089